Vimarsana
Biggest News Aggregation in the World

Webull Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webull Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webull Advisors Today - Breaking & Trending Today

Webull Announces Partnership with TradingView - Thailand Business News - Vimarsana News

Webull Announces Partnership with TradingView - Thailand Business News

Leading mobile brokerage now offers advanced charting platform and social network for traders.      

BioSig Joins Webull Corporate Connect - Vimarsana News

BioSig Joins Webull Corporate Connect

Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization,

Alarum Technologies : Immediate Report - Vimarsana News

Alarum Technologies : Immediate Report

Alarum Joins Webull Corporate Connect Service Platform TEL AVIV, Israel, June 16, 2023 - Alarum Technologies Ltd. , a global provider of enterprise and consumers... | June 16, 2023

Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform - Vimarsana News

Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform

NEW YORK, May 23, 2023 -- Tiziana Life Sciences Ltd.  , a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that they... | May 23, 2023

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform - Vimarsana News

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform

NEW YORK, May 23, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that they are now participating